Financials

News Discussions Technicals Seasonals

ZLDAF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Zelira Therapeutics Ltd. operating, investing, and financing activities

ZLDAF free cash flow for H2 24 is -1.77 M USD. For 2024, ZLDAF free cash flow was -2.93 M USD and operating cash flow was -2.93 M USD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—